baber/WOPTO huggingface dataset:
Patent SG-61389-G (SG)
Title: Wire stuffing cover
IPC: H01R4/24
Filed: 1989-09-08
Abstract: A one-piece wire stuffing cover having a series of tubular terminal receiving sockets with wire gripping slots at front and rear faces and respective wire stuffers between the slots, lead-out openings for wires terminated by the cover being provided in the sockets rearward of the wire stuffers. The lead-out openings are provided by rebated portions in the sockets which define wire engaging shoulders extending across a rear axial end of the terminal for strain relief. The slots in the rear face diverge progressively to release the wire at the rear face during termination.
Patent SG-75184-G (SG)
Title: Flexible container for bulk material
IPC: B65D88/16
Filed: 1984-10-30
Abstract: The present invention relates to a flexible container for lifting, transport and storage of bulk material. The container has four lifting loops (7). The lifting loops (7) are direct extensions of the container's sidewalls (2A-4B) and are thereby integrated parts of the container itself. Each lifting loop (7) has a width of up to 1/4 of the container's circumference. The bottom of the container can be made in different ways and is preferably an integrated part of the container itself.
Patent IE-800102-L (IE)
Title: N-benzylimidazoles
IPC: A61P25/06
Filed: 1980-01-18
Abstract: The N-(substituted benzyl) imidazoles are selective enzyme inhibitors and thus are useful in the treatment of heart disease, circulatory and vascular problems.
[US4448781A]
Patent IE-800202-L (IE)
Title: Tablets with controlled liberation of the active agent
IPC: A61K9/26
Filed: 1980-02-01
Abstract: A process for the preparation of matrix-type tablets with retarded liberation of the active agent. The liberation of the active agent from the tablets takes place at a speed that has been adjusted precisely in advance. In the granulation process, polymethacrylate plastics insoluble in neutral or slightly acid water either as dissolved in an organic solvent or as a water dispersion are used as the retarding matrix substance. Before the tablets are compressed, an ester of a large-molecule fatty acid or a product obtained from same by means of hydrogenation is mixed into the grain mix in order to adjust the rate of liberation of the active agent.
[US4351825A]
Patent IE-34976-L (IE)
Title: Pipe joints
IPC: F16L19/06
Filed: 1971-03-02
Abstract: 1276998 Pipe joints FORSHEDA GUMMIFABRIK AB 19 April 1971 [2 March 1970] 22700/71 Heading F2G A spigot-and-socket joint having a packing ring 16 of rubber is stiffened by means of a supporting ring 17 which comprises a pair of rings 18, 19 which mutually interact at generally tapered surfaces 20, 21 so that when the inner ring 19 is forced axially into the outer ring 18, the rings press radially against spigot and socket walls 14, 15. In the embodiment shown, the pipe socket and spigot are of cast iron. The outer ring 18 has a flange 24 which abuts the end of the socket 11 and the surfaces 20, 21 have annular ridges of a hook or barb shape (22, 23) (Fig. 2, not shown) to allow easy relative motion of the rings in the direction in which the joint is tightened but relative motion in the opposite direction is resisted. The rings, which are preferably of plastics material, may be split in at least one place to allow them to be opened out and snapped around the pipe spigot prior to insertion into the socket. A tendency for the supporting ring 17 to roll out of the annular space when the joint is simultaneously bent and rolled is inhibited by the frictional engagement of further annular ridges 25 on the outer ring 18 with the socket wall.
[GB1276998A]
Patent IE-830263-L (IE)
Title: Anti-hypertensive compositions
IPC: A61K31/455
Filed: 1983-02-09
Abstract: A pharmaceutical composition comprises one or more essential fatty acids such as  gamma -linolenic acid in conjunction with a bile salt binder or niacin or both. The compositions may be administered to reduce blood cholesterol levels.
Patent IE-40613-L (IE)
Title: Printing apparatus
IPC: B29C48/92
Filed: 1974-02-22
Abstract: 1468360 Injection moulding COLORFLO Ltd 6 March 1974 [9 March 1973] 11536/73 Heading B5A [Also in Division B6] Material is moulded on to a substrate by introducing it into the recesses 18 of an intaglio printing plate by a feed device having a chamber 34 into which the material is fed and which has an outlet 42 which is closed by a valve element connected to a movable member biased to a position where the valve is closed, but so positioned that the movable member, and hence the valve can be moved by applying compressed fluid, e.g. compressed air, the inlet 36 then being closed and the material pressurized to flow from the outlet to the recesses. As shown, chamber 32 receives compressed air from line 58 to pressurize the material, and to open valve 44, 46, biased closed by spring 54. The supply of compressed air may be under the control of a microswitch actuated by closing movement of a pair of press jaws, are carrying the plate and assembly 12 (Fig. 1, not shown). A number of devices 12 may be provided, and each may supply a different-colour material. If the material is moulded on to a substrate, e.g. a sheet of metal or a silicone release paper, then, after allowing the material to at least partially set, the material may be stripped from the substrate. This method may be applied to the production of gaskets.
[GB1468360A]
Patent IE-37417-L (IE)
Title: Separating oxo-dibenzofuranbutyric acids.
IPC: C07D307/91
Filed: 1973-03-16
Abstract: A process for the separation of gamma -oxo-2-dibenzofuranbutyric acid from a mixture of said acid and gamma -oxo-3-dibenzofuranbutyric acid is disclosed. Such a mixture is obtained by the prior art method of preparing gamma -oxo-2-dibenzofuranbutyric acid from dibenzofuran and succinic anhydride in a Friedel-Crafts reaction. The mixture of acids is converted to a mixture of their corresponding lower alkyl esters which is separated by recrystallization or chromatography into its component alkyl esters. Hydrolysis of the lower alkyl ester of gamma -oxo-2-dibenzofuranbutyric acid gives the desired corresponding acid.
[US3985774A]
Patent IE-880631-L (IE)
Title: Process for chlorination of phenols
IPC: C07C39/32
Filed: 1988-03-04
Abstract: The chlorophenols, e.g., 2,4,6-trichlorophenol, are efficiently prepared by chlorinating an ortho-/para-substituted phenolic compound with gaseous chlorine, whether in molten state or in a solvent reaction medium, in the presence of a catalytically effective amount of a primary, secondary or tertiary amine.
Patent IE-800811-L (IE)
Title: Polymers containing amide linkages
IPC: C08G69/00
Filed: 1980-04-22
Abstract: Polymers containing amide linkages can be formed in good yields by the dehydrative addition polymerization of alpha, beta-unsaturated monocarboxylic acids or the ammonium salts thereof. These polymers are suitable for use as fibers, plastics, films and molding resins.
[US4283524A]
Patent IE-34369-L (IE)
Title: Collecting sheets cut from a moving web
IPC: B65H29/66
Filed: 1970-07-07
Abstract: This apparatus for receiving sheets cut from a web comprises only mechanical means for retarding and braking the successive cut sheets so that they overlap one another before being delivered. (From US3685823 A) [FR2052078A5]
Patent IE-890905-L (IE)
Title: A process for preparing 3-unsubstituted cephalosporins and 1-carba(dethia) cephalosporins
IPC: C07D501/20
Filed: 1989-03-22
Abstract: A process for preparing 7 beta -acylamino (or 7 beta -protected amino)-3-H-1-carba(1-dethia)-3-cephem-4-carboxylic acid esters and the corresponding cephalosporins is provided. 7 beta -Acylamino (or 7 beta -protected amino)-3-halo (or 3-sulfonyl ester)-1-carba(dethia)-3-cephem carboxylic acid esters and the corresponding cephalosporins are reduced with Pd(O) and a tetra-C2-C6 alky stannane and, when a 3-sulfonyloxy ester is reduced, the process is carried out in the presence of an alkali metal halide. 3-Sulfonyloxy-3-cephem esters such as 3-mesylate, 3-tosykate and 3-triflate are employed.
Patent FI-811250-L (FI)
Inventor: KRENITSKY THOMAS ANTHONY
IPC: C07H19/04
Filed: 1981-04-22
Abstract: A method for the preparation of 4-substituted-1- beta -D-ribofuranosyl-1H-imidazo- [4,5-c)-pyridines by enzymatic ribosylation of the corresponding 4-substituted-1H-imidazo-[4,5-c]-pyridine is disclosed. In particular the preparation of 4-amino-1- beta -D-ribofuranosyl-1H-imidazo-[4,5-c]-pyridine (3-deazadenosine) is described.
Patent FI-850247-L (FI)
Inventor: NUTTENS HUGO JOZEF CORNEEL
IPC: C08F10/02
Filed: 1985-01-18
Abstract: Synthetic polyethylene wax having low molecular weight of 250 to 3000 and a density of 0.930 to 0.950 is prepared in a high pressure process at pressures of at least 800 bar using a carbonyl compound such as acetaldehyde as chain transfer agent. The resulting wax with incorporated CO has good compatibility in hot melt systems, and may be stripped to remove light ends, increase density and crystallinity and improve thermal stability.
Patent FI-851793-L (FI)
Inventor: PROUGH JAMES ROBERT
IPC: D21F1/00
Filed: 1985-05-07
Abstract: @ The latency of mechanical pulp is removed in a quick and simple manner. After refining of comminuted cellulosic material in a refiner (12) to produce mechanical pulp, the pulp is fluidized at a consistency of about 5-30% to remove latent properties. For instance, the pulp is diluted (if necessary) to a consistency of between about 5-30% (preferably 8-15%), and the pulp is then merely pumped to a further treatment stage. Pumping is effected utilizing a centrifugal pump (15) which fluidizes the pulp, the fluidization imparting sufficient energy to the pulp to remove the latent properties. The pulp may be pumped to a storage stage (23) prior to passage to a screening stage (21), and can be pumped in a direct (non-return) path (20) from the pump to the screening stage. If desired or necessary, a portion of the pumped pulp can be recirculated (in line 26, 26') and pumped again to ensure that sufficient energy is imparted thereto to effect latency removal.
Patent IE-42697-L (IE)
Title: Reproducing information of an optical character
IPC: G11B7/24
Filed: 1976-05-19
Abstract: Apparatus for reproducing information recorded on a flexible, opaque tape in the form of successive images having a high resolution such that they cannot be read by the naked eye. The apparatus comprises a tape drive for advancing the tape to and through a presentation zone. A luminous source provides a luminous scanning flux directed towards the presentation zone. A photo-sensitive device receives a beam of luminous flux reflected from the image on the tape at the presentation zone and transforms the variations in luminous intensity into electrical signals. If the successive images are television fields, then the electrical signals are used to produce a visible image on a television receiver. Alternatively if the images are documentary records, the electrical signals are fed to a viewing apparatus for reading by a user or copying.[US4133005A]
Patent IE-851262-L (IE)
Title: Pharmaceutical compositions
IPC: A61K47/04
Filed: 1985-05-21
Abstract: A pharmaceutical composition comprising a freely flowable powder, the powder comprising a porous, high absorption silica or silicate having absorbed therein at least 10% by volume of a liquid, pharmaceutically active composition, based on the weight of powder plus liquid, provided that when the liquid pharmaceutically active composition is a corticoid solution the silica or silicate has a mean particle size of at least 10 mu m in diameter.
[US4719228A]
Patent IE-851546-L (IE)
Title: Brazed composite compact implement
IPC: E21B10/46
Filed: 1985-06-21
Abstract: Disclosed is an improved implement comprising a cemented carbide supported composite abrasive compact which is brazed to a cemented carbide substrate with a brazing filler metal having a liquidus substantially above 700 °C. The composite compact preferably is a composite polycrystalline diamond compact. The brazing filler metal is a brazing alloy having a liquidus not substantially above 1,004 °C and which has the following composition, by weight:Au 18-39.5%Ni 3.5-14.5%Pd 2.5-10.5%Mn 7.5-9.0%Cu Balance.
Patent IE-821632-L (IE)
Title: Imidazolyl-tetrahydropyridazines
IPC: A61K31/50
Filed: 1982-07-06
Abstract: The invention relates to new 6-{4-( omega -(1-imidazolyl)-alkyl)-phenyl}-3-oxo-2,3,4,5-tetrahydro-pyridazines having the general formula I <IMAGE> I and acid addition salts thereof, and to a process for the treatment of inflammatory, atherosclerotic and thromboembolic diseases especially in humans.
[US4507298A]
Patent IE-38350-L (IE)
Title: Electrolytic cells
IPC: C25B9/23
Filed: 1973-10-04
Abstract: A method and apparatus for the electrolysis of an aqueous solution containing alkali metal ions, for example, the electrolysis of brine to produce chlorine and caustic. In one embodiment, a composite membrane comprising at least an ionconductive polymer and a metal permeable to alkali metal is used in an electrolytic cell. An illustration of such a polymer is a perfluorocarbon polymer containing sulfonic acid or sulfonate groups, in intimate contact with a layer of mercury. Another aspect is the use of elevated pressures or other techniques substantially to eliminate the presence of normally gaseous products from the electrolyte. For example, high pressures may be employed to dissolve chlorine in a brine electrolyte and/or liquefy it. In another aspect, sodium sulfate is electrolyzed in a cell comprising a composite membrane, a foraminous anode, and a diaphragm between the composite membrane and anode; the oxygen produced is withdrawn through the anode.
[US3864226A]
Patent IE-832125-L (IE)
Title: Chloracetamides
IPC: C07D417/12
Filed: 1983-09-12
Abstract: Derivs. Ar-NY-COCH2-Cl (I) are new. (where Ar is opt substd. 5-pyrimidinyl; and Y is 1-8C alkyl, 3-8C alkenyl, 3-8C alkynyl, 3-8C cycloalkyl, 5-8C cycloalkenyl w (3-8C cycloalkyl)-(1-5C alkyl) opt. substd. by F, Cl or Br; a Y is a gp.-CH(R1)-CO-Y1 in which R1 is H or 1-5C alkyl and -CO-Y1 is an ester a amide function; or Y is a gp. -R2-Az in which R2 is methylene or ehtylene opt. substd. by 1-5C alkyl, and Az is a di- or triazole ring linked to R2 via nitrogen or is a 5-membered aromatic hetero-ring, linked to R2 via carbon, contg. 1-3 hetero atoms selected from O, S and N, or a pyrimidinyl gp.; or Y is a gp. -A-O-R3 in which R3 is H, opt. substd. 1-8C alkyl, 3-8C alkenyl, 3-8C alkynyl, 3-8C cycloalkyl, 5-8C cycloalkenyl or (3-8C cycloalkyl)-(1-5C alkyl) or a gp. N=C (R4)(R4') (where R4 and R4' are H, 1-5C alkyl, 3-5C alkenyl,3-5C alkynyl, 3-8C cycloalkyl, 5-8C cycloalkenyl or (3-8C cycloalkyl) -(1-5C alkyl) opt. substd. by F , Cl or Br, or alkenyl, at least one of R4 and R4' being other than H) and A is a hydrocarbon residue which can be linked with R3 to form a saturated O-contg. hetero ring contg. 1 or 2 O-atoms as hetero atoms, provided that A separates the O- and N-atoms to which it is linked by at least 2C -atoms; or Y is a gp. -CH(R5)-C(R5'):NOR4" in which R4" is as defined for R4 above and R5 and R5' are each H or CH3 or together represent tri- or tetramethylene; or Y is alkenyl or -CH2CH:C:CH2, or Y is a gp. -CH(R6)-B in which R6 is H or 1-3C alkyl and B is N-methylacetamide or a 5-membered lactan ring linked to the CH(R)- gp. via nitrigen). Cpds. have affects on plant growth and are suitable for use as herbicides with selectivity with respect to bultivated plants, e.g. cereals or maize and, esp., broadleaved cultures such as cotton, sugar beet, potatoes, sunflower, rape or flax. The cpds. have favourable soil resistance.
[FR2532935A1]
Patent IE-43186-L (IE)
Title: Adjustable chair
IPC: A61G15/08
Filed: 1976-09-28
Abstract: A surgical chair for a doctor embodying an infinitely elevationally adjustable seat connected with a support column, a stand tube arranged within the support column, at which there is attached a base frame equipped with rollers and a lifting device within the stand tube. The lifting device is operatively connected with the support column and can be unblocked by a lever system so that the seat, depending upon the degree of loading thereof, is elevationally adjustable. A foot pedal located between two overhang members of the base frame is arranged with its upper edge at most 4 centimeters above the floor and with adjustable freedom of movement with respect to the floor. The foot pedal is secured by a lever to an angle lever pivotably mounted at the stand tube and acts upon a plunger of the lifting device. At least three guide grooves are provided at the support column and extend uniformly about its inner periphery and parallel to its central axis. At least two superimposed sets of spaced rollers are secured at the outer periphery of the stand tube in operable association with the guide grooves arranged at the support column.
[US4061304A]
Patent IE-852435-L (IE)
Title: Cutting and recovery tool for an underwater wellhand
IPC: E21B31/20
Filed: 1985-10-04
Abstract: A cutting and recovery tool for a well-head, having a housing which is adapted to engage with a side wall of the well-head to lock them together, and a mandrel extending through the housing and rotatable relative to the housing and adapted to carry a radially-acting cutter which severs the well-head below the area of engagement of the housing. This allows the well-head to be severed and withdrawn in a single operation.
[US4703802A]
Patent IE-782561-L (IE)
Title: Thiazolidinediones
IPC: C07D277/34
Filed: 1978-12-28
Abstract: Thiazolidine-2,4-dione derivatives, in the form of racemates or optically active isomers, corresponding to the formula (I) <IMAGE> (I) in which n=2 or 3, R1=H, alkyl, benzoyl, acetyl or optionally substituted benzyl, R2=H or alkyl, R3=phenyl, which is optionally substituted by halogen, alkyl, alkoxy, NO2, CF3 or CF3S, or naphthyl, and R4=H, alkyl, phenyl, benzoyl or allyl, and acid addition salts thereof. These compounds are useful in therapy as anti-convulsants or anti-depressants.
[US4349683A]
Patent IE-892680-L (IE)
Title: A new method of treating erectile dysfunction
IPC: A61K31/5575
Filed: 1989-08-21
Abstract: Lipophilic active substance composition and its use in a new method of treating erectile dysfunction by administration thereof, optionally together with a hydrophilic vehicle and optionally an antibacterial agent into the urethra.
[EP0357581A1]
Patent IE-892858-L (IE)
Title: Process for the preparation of 1-adamantane derivatives
IPC: C07C323/20
Filed: 1989-09-06
Abstract: This process consists in reacting a 1-acyloxyadamantane whose acyl radical contains from 1 to 4 carbon atoms with a receptor compound, in a solvent of the linear aliphatic or cycloaliphatic hydrocarbon type, in the presence of concentrated sulphuric acid at room temperature. 
<??>This process is very particularly intended for the adamantylation of aromatic compounds.
Patent IE-892899-L (IE)
Title: Slitting absorbent boards
IPC: B26F3/04
Filed: 1989-09-11
Abstract: Apparatus having two spaced rolls (10,11) with a plurality of intermeshed disc-like teeth (23). The rolls form a nip into which an absorbent board (15) is fed for partial slitting. The board is comprised of both long and short fibers. The apparatus separates the short fibers at each slit while leaving a number of long fibers in tack to maintain a unitary structure. Advantageously, the teeth of one roll form gaps (C) slightly wider than the thickness of the long fibers with the teeth of the other roll to permit passage of the long fibers.
[EP0360472A2]
Patent IE-893700-L (IE)
Title: Anti-atherosclerotic diaryl compounds
IPC: C07C233/07
Filed: 1989-11-20
Abstract: The present invention is concerned with the compound of formula (I)and salts, solvates and physiologically functional derivatives thereof, processes for the preparation of this compound, pharmaceutical formulations containing it and their use in medicine.
Patent IE-930804-L (IE)
Title: Regulatory region for heterologous gene expression in yeast
IPC: C12N15/81
Filed: 1985-10-29
Abstract: Novel DNA sequences which are responsive to the presence of methanol, catabolite non-repressing carbon sources and carbon source starvation are provided. In addition, novel constructs including these DNA sequences, as well as transformed organisms therewith are provided. Processes for producing the DNA sequences and constructs of the invention are detailed. The production of polypeptide product under the control of the regulatory regions of the invention is demonstrated.
[EP0483115A2]
Patent NO-761351-L (NO)
Inventor: SHIRASUNA M
IPC: A63F3/02
Filed: 1976-04-21
Abstract: SPILL.
Patent NO-772341-L (NO)
Title: Fargede, spiselige matvarehylstre av collagen
Inventor: HIGGINS THOMAS ENGEL
IPC: A22C13/00
Filed: 1977-07-01
Abstract: Fargede, spiselige matvarehylstere av collagen.
Patent NO-792566-L (NO)
Inventor: SILVERWATER BERNARD F
IPC: G01L19/12
Filed: 1979-08-03
Abstract: A magnetic differential pressure indicator is provided for detecting and indicating a pressure differential thereacross that is greater than a predetermined value in a fluid system. A thermal lockout effective even at high internal fluid pressures prevents false actuation of the magnetic indicating means at low temperatures due to increased viscosity of the system fluid.
Patent NO-810054-L (NO)
Inventor: PROBST JOACHIM
IPC: C08F8/44
Filed: 1981-01-09
Abstract: The aqueous solution of a statistical terpolymer containing quaternized amino groups and having a regular chemical structure of (a) from 8 to 20%, by weight, of N,N-dimethylaminoethyl acrylate and/or N,N-dimethylaminoethyl methacrylate; (b) from 45 to 80%, by weight, of styrene; and (c) from 8 to 35%, by weight, of acrylonitrile; the sum of (a) to (c) being 100%, by weight, and at least 10% of the dimethylamino groups of the terpolymer being quaternized and the remainder protonated is suitable as cationic paper sizing agent.
Patent NO-810320-L (NO)
Inventor: LEVIN PHILIP STEPHEN
IPC: C03C13/00
Filed: 1981-01-29
Abstract: An optical waveguide filament is disclosed which comprises a cladding layer, a core and a barrier layer disposed between the core and cladding. The barrier layer comprises silica doped with B<sub>2</sub>O<sub>3</sub>, P<sub>2</sub>O<sub>5</sub> and GeO<sub>2</sub>. The core consists of an inner region and an outer region, the boundary between which is referred to as the core break-point. In the outer region of the core, the concentration of B<sub>2</sub>O<sub>3</sub> decreases linearly from its barrier layer level to zero at the core break-point, the P<sub>2</sub>O<sub>5</sub> increases at a rapid rate from the barrier layer level to a first concentration level at the core break-point and the GeO<sub>2</sub> remains at a constant value between zero and the barrier level. In the outer region of the core, the GeO<sub>2</sub> increases from some level up tothe barrier layer level to a greater value at the filament axis in a power law fashion. The P<sub>2</sub>O<sub>5</sub> also increases in a power law fashion from the value thereof at the core break-pointto a higher value at the filament axis, the increase in concentration of P<sub>2</sub>O<sub>5</sub> in the outer core region increasing at a rate greater than the concentration of P<sub>2</sub>O<sub>5</sub> would increase if the power law P<sub>2</sub>O<sub>5</sub> gradient extended into the outer core region. Also disclosed is a method of making a preform for such a filament.
Patent NO-840213-L (NO)
Inventor: ROSSY PHILLIP A
IPC: C07D401/14
Filed: 1984-01-20
Abstract: Novel 6-(acylaminaryl)-3(2H)-pyridazinones of the formula    <IMAGE> (I)  where R1, R2, R3, R4, A and B have the meanings given in the description, and their preparation are described. The compounds have thrombocyte aggregation-inhibiting activity.